CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed

Berkeley Heights, NJ– November 18, 2020 – CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news